Laura Ridolfi Selected Research

Laura Ridolfi Research Topics

Disease

27	Melanoma (Melanoma, Malignant) 12/2023 - 03/2002
23	Neoplasms (Cancer) 12/2023 - 03/2003
5	Neoplasm Metastasis (Metastasis) 08/2018 - 03/2003
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 07/2004
1	Microsatellite Instability 10/2023
1	Breast Neoplasms (Breast Cancer) 03/2023
1	Infertility (Sterility) 06/2022
1	Brain Neoplasms (Brain Tumor) 05/2014
1	Thrombocytopenia 1 01/2012
1	Diarrhea 01/2012
1	Uveal melanoma 01/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2011
1	Hypersensitivity (Allergy) 01/2010
1	Splenomegaly 09/2008
1	Lymphadenopathy 09/2008
1	Myalgia 03/2002
1	Hyperthermia 03/2002
1	Arthralgia (Joint Pain) 03/2002
1	Fever (Fevers) 03/2002

Drug/Important Bio-Agent (IBA)

9	Interleukin-2 (IL2)IBA 01/2021 - 03/2002
5	VaccinesIBA 06/2022 - 01/2010
4	Immune Checkpoint InhibitorsIBA 12/2023 - 10/2018
4	CytokinesIBA 01/2018 - 01/2009
4	Neoplasm Antigens (Tumor Antigens)IBA 09/2014 - 12/2003
4	IpilimumabIBA 05/2014 - 11/2011
4	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 05/2013 - 08/2006
3	AntibodiesIBA 01/2020 - 01/2017
3	AntigensIBA 09/2014 - 06/2010
2	Biomarkers (Surrogate Marker)IBA 09/2014 - 11/2011
2	Monoclonal AntibodiesIBA 01/2012 - 11/2011
2	Messenger RNA (mRNA)IBA 11/2011 - 01/2010
1	Chimeric Antigen ReceptorsIBA 03/2023
1	NitrogenIBA 06/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Melanins (Melanin)IBA 01/2021
1	pembrolizumabIBA 01/2020
1	NivolumabIBA 01/2020
1	Granzymes (Granzyme)IBA 01/2019
1	Contrast MediaIBA 10/2018
1	dabrafenibIBA 08/2018
1	trametinibIBA 08/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2018
1	MicroRNAs (MicroRNA)IBA 06/2014
1	Temozolomide (Temodar)FDA LinkGeneric 05/2013
1	Alanine (L-Alanine)FDA Link 01/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2012
1	SteroidsIBA 01/2012
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2011
1	Immunoglobulin G (IgG)IBA 06/2010
1	HLA-DR Antigens (HLA-DR)IBA 06/2010
1	Peptides (Polypeptides)IBA 06/2010
1	Histocompatibility Antigens Class IIIBA 06/2010
1	Cancer VaccinesIBA 01/2010
1	Proteins (Proteins, Gene)FDA Link 01/2010
1	Cisplatin (Platino)FDA LinkGeneric 04/2009
1	fotemustine (Muphoran)IBA 04/2009
1	Interferon-alpha (Interferon Alfa)IBA 04/2009
1	Environmental BiomarkersIBA 07/2004
1	Fas Ligand Protein (Fas Ligand)IBA 03/2003
1	InterleukinsIBA 03/2003
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2002

Therapy/Procedure

16	Immunotherapy 10/2023 - 03/2002
11	Therapeutics 03/2023 - 03/2002
5	Drug Therapy (Chemotherapy) 10/2018 - 03/2002
3	Radiotherapy 01/2021 - 07/2014
1	Molecular Targeted Therapy 12/2023
1	Withholding Treatment 06/2012
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2011
1	Metastasectomy 03/2003
1	Intralesional Injections 03/2002